EMA To Shed More Light On Interactions With Industry
This article was originally published in Scrip
The European Medicines Agency has been interacting with its various stakeholders since it was set up in 1995, and has had formal rules on its relations with patients and health professionals in place for some years.
You may also be interested in...
Progress is being made towards the implementation of the EU’s new patent system, but the UK’s insistence on severing all ties with the European Court could spell the end for its participation.
The recruitment process for the new executive director of the European Medicines Agency seems to be running to schedule.
Russia’s new drug traceability system won’t now be implemented until July, but companies that are ready and able are being encouraged to put the system through its paces in order to flush out any glitches.